Vice Dean of Research, College of Medicine
Senior Associate Vice President for Research, Office of Health Sciences
Director, Center for Critical Care and Respiratory Medicine
Executive Director, Center for Personalized Health Care
Clay Marsh, MD, has been a member of the medical staff at Ohio State since 1985. He earned his medical degree from West Virginia University and completed his residency in internal medicine at Ohio State, where he served as chief resident.
Marsh has won numerous teaching awards and has been recognized nationally for his research and devotion to teaching and mentorship of medical students, residents and fellows.
He has published more than 230 journal articles, abstracts and book chapters, and holds one patent with five more pending. He is associate editor of the Journal of Investigative Medicine and the American Journal of Physiology.
He also has served as chairman of the board of the Stanley Sarnoff Research Foundation and as a national leader in pulmonary medicine on the Battelle Bioinitiative in Pulmonary Medicine.
Marsh was approved by The Ohio State University Board of Trustees in June 2009 to appointments as senior associate vice president for research in the Office of Health Sciences, vice dean for research in the College of Medicine and executive director of the OSU Center for Personalized Health Care.
In these new roles, he will lead planning and expansion of OSU Medical Center’s myriad research endeavors, which from 2000-2008 increased in funding by more than $120 million to $199.4 million. Marsh also will be responsible for recruitment of key researchers and lead the introduction of advanced technology initiatives to the Medical Center.
Marsh will actively advance the Medical Center’s growing reputation as an international leader in personalized health care, a field that utilizes genetic-based information to develop tailored medical treatments, in hopes of transforming medicine from a reactive, population- and disease-based approach, to proactive, personalized and wellness-based medicine.
At Ohio State, Dr. Zheng earned a doctoral degree in Public Policy and Management in 1999 and an MBA in 2003. He has served in numerous leadership positions since joining the University in 1997 as senior planning manager, business performance officer, director of Technology and Commercialization Partnerships and director of Data Analysis and Information Services.
Dr. Zheng will direct not only the day-to-day operation of the CPHC, but also core initiatives that will involve OSUMC and other academic medical centers and organizations throughout the country and the world.
Lee Xu, MD, PhD, MBAXu has more than 20 years of research experience in oncology and molecular therapy of cancer. She has published numerous papers in leading international journals. Prior to her current role, Xu was a Vice President and Chief Operating Officer of OncoImmune, a biopharmaceutical company developing therapeutics for autoimmune disease and cancer. She was a principal investigator funded by the NIH and the US Department of Defense. Xu received her M.D. and Ph.D. from China Medical University and completed her postdoctoral training at the University of North Carolina at Chapel Hill. She also holds an MBA from the Ohio State University.
Xu is responsible for the development of PHC related research and continued medical education programs.
Graduating from The Ohio State University in 1999, Philips earned a Bachelor of Arts degree in Journalism with an emphasis on public relations and also earned a minor in English. She has served in many marketing communications roles in both health care and technology with agency, private industry and academic experience. Additionally, she holds a dual position within OSUMC’s Communications and Marketing Department specializing in research communications for the entire organization.
Philips will be involved in all the day-to-day activities of CPHC’s strategic communications in conjunction with the core initiatives of the Center.
